2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$11.36+$0.010 (+0.09%)
Price as of Oct 22, 2026 7:30 PM EDT- $221.7MMarket Cap
- -28.15%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$11.36+$0.010 (+0.09%)
Earnings Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 13.91% | ||
12-Month Momentum | -25.26% | ||
3-Month Risk Adjusted Momentum | 69.05% | ||
12-Month Risk Adjusted Momentum | -52.30% |
True Yield
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 4.53% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 13 |